Preparation of Gentamicin Sulfate Nanoparticles using Eudragit RS-100 and Evaluation of Their Physicochemical Properties

被引:1
|
作者
Nejati, Ladan [1 ]
Maram, Nader Shakiba [1 ]
Ahmady, Amanollah Zarei [2 ]
机构
[1] Ahvaz Jundishapur Univ Med Sci, Nanotechnol Res Ctr, Ahvaz, Iran
[2] Ahvaz Jundishapur Univ Med Sci, Marine Pharmaceut Sci Res Ctr, Ahvaz, Iran
关键词
Eudragit RS-100; double emulsion; gentamicin; nanoparticles; RS100; NANOPARTICLES; DRUG-RELEASE; RS; 100; DELIVERY; DICLOFENAC; GELATIN; PROFILE; SYSTEM;
D O I
10.1142/S0219581X21500496
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Improving permeability and absorption of drugs are critical research challenges in pharmaceutical science. Gentamicin sulfate is an aminoglycoside antibiotic, which is very active against gram-negative bacteria; however, it has very poor bioavailability. This study aimed to prepare gentamicin nanoparticles with the intention of increased bioavailability. Accordingly, Eudragit RS-100 nanoparticles loaded with gentamicin sulfate were prepared by the double emulsification and solvent evaporation method, a proper technique for encapsulating hydrophilic molecules. Nanoparticles' suspensions with polymer to drug ratios of 1:1 (F-a) and 2:1 (F-b) were prepared, lyophilized and evaluated for their production yield, physicochemical properties and morphology. The mean particle size was 195.67nm and 228nm for F-a and F-b, respectively. The formulations' loading efficiencies were relatively high (85.73 for F-a and 85.20 for F-b). The nanoparticles' surface charge (+40.5mV) was sufficient to inhibit their aggregation and facilitate the nanoparticles' absorption through the gastrointestinal tract. The results of differential scanning calorimetry (DSC) and Fourier transform infrared spectroscopy (FT-IR) revealed that drug and polymer stabilized each other by physical interactions between their functional groups. Both formulations presented an initial burst drug release of nearly 20% after 30min in phosphate buffer (pH = 7.4). After 24h, F-b did not release the drug completely, while F-a released the whole drug. Overall, nanoparticles with proper characteristics were obtained. This study puts forward the necessity of conducting further research in order to explore the intestinal absorption of these nanoparticles and the possibility of being utilized for oral administration of gentamicin sulfate.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Preparation and Characterization of Water-soluble Microcapsule for Sustained Drug Release Using Eudragit RS 100
    Park, Jeong-Min
    Park, Soo-Jin
    MACROMOLECULAR RESEARCH, 2010, 18 (12) : 1191 - 1194
  • [22] Preparation and characterization of water-soluble microcapsule for sustained drug release using Eudragit RS 100
    Jeong-Min Park
    Soo-Jin Park
    Macromolecular Research, 2010, 18 : 1191 - 1194
  • [23] Preparation and analgesic activity of Eudragit RS100® microparticles containing diflunisal
    Pignatello, R
    Amico, D
    Chiechio, S
    Spadaro, C
    Puglisi, G
    Giunchedi, P
    DRUG DELIVERY, 2001, 8 (01) : 35 - 45
  • [24] Properties of tolmetin-loaded Eudragit RL100 and Eudragit RS100 microparticles prepared by different techniques
    Pignatello, R
    Vandelli, MA
    Giunchedi, P
    Puglisi, G
    STP PHARMA SCIENCES, 1997, 7 (02): : 148 - 157
  • [25] Triamcinolone acetonide-Eudragit® RS100 nanofibers and nanobeads: Morphological and physicochemical characterization
    Payab, Shahriar
    Davaran, Soodabeh
    Tanhaei, Ali
    Fayyazi, Behnam
    Jahangiri, Azin
    Farzaneh, Amir
    Adibkia, Khosro
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2016, 44 (01) : 362 - 369
  • [26] Experimental Investigation on Efficacy of Eudragit RS 100 Polymer in Prolonging Glibenclamide Release by Intragastric Floating Microsphere Formulation and Physicochemical Evaluation
    Tripathi D.
    Yadav P.
    Mishra G.
    Rai A.K.
    Micro and Nanosystems, 2024, 16 (02) : 123 - 138
  • [27] Controlled release theophylline delivery systems using Eudragit RS 100
    Badawi, AA
    El Samaligy, M
    Badawi, SS
    Aziz, RL
    PHARMAZIE, 1998, 53 (08): : 556 - 558
  • [28] Mucoadhesive Properties of Eudragit®RS100, Eudragit®S100, and Poly(ε-caprolactone) Nanocapsules: Influence of the Vehicle and the Mucosal Surface
    Paula Dos Santos Chaves
    Luiza Abrahão Frank
    Alejandro Germán Frank
    Adriana Raffin Pohlmann
    Sílvia Stanisçuaski Guterres
    Ruy Carlos Ruver Beck
    AAPS PharmSciTech, 2018, 19 : 1637 - 1646
  • [29] Oral evaluation in rabbits of cyclosporin-loaded Eudragit RS or RL nanoparticles
    Ubrich, N
    Schmidt, C
    Bodmeier, R
    Hoffman, M
    Maincent, P
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 288 (01) : 169 - 175
  • [30] Preparation of alginate nanoparticles using Eudragit E100 as a new complexing agent:: Development, in-vitro, and in-vivo evaluation
    Sonavane, Ganeshchandra S.
    Devarajan, Padma V.
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2007, 3 (02) : 160 - 169